This survey is intended for scientific communities broadly and is intended to be completed by science outreach professionals as well as others in their academic community.
This survey is a part of the NSF-funded Grant #1854018
There is a huge spectrum of symptom presentation in people with COVID-19. While some people remain asymptomatic, there are several known pre-existing conditions (comorbidities) that correlate with increased disease severity. In this D4P presentation, scientist Viktor Belay will present data from “Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes,” published April 30, 2020. The authors in this report set out to better understand the impact of COVID-19 in patients with type 2 diabetes through a retrospective study on affected patients in Hubei Province, China. ... See MoreSee Less
I believe diabetes goal is to get diabetics HbA1c <8. The study indicated >10 as uncontrolled group. I’m wondering if more stringent HbA1c levels would increase or decrease the death rate...What do you think?
Great talk today- really enjoyed. Thank you
Good job, presenter!
Have to go now. But this has been great and all the best with future research on this!
Really good presentation. Presenter is very clear!
Given that a p-value represents the probability that a phenomenon happens by chance, what p-vale would we expect from a sig test of something that is most probably NOT random?
Hello, and welcome to Data for the People!
Hi All! Did the paper mention the use of ACE inhibitors/ ARB medications. (which are often given to Diabetic patients to treat hypertension) There was talk early on about ARBs
Please share your questions, here, for our d4p presenter, Viktor!
Thank you, Victor!
Could there be comorbidities (like cardiovascular disease), demographics (age), or concomitant medications that affected the outcomes?
a) .9, b) .001, c) 1, d) .67
Keeping sending your questions!
Hello.. joining in
The answer is B!
Register for next week (AKA our LAST d4p of the 2019-2020 school year!) rocku.zoom.us/webinar/register/WN_pxuR9-fZQTuwY2QfAzI0cw
Please take our survey: www.surveymonkey.com/r/NDKRLBZ
Today and everyday we stand with our black community in the fight against inequality, injustice and racism.
Visit bit.ly/BlackLivesAction (case sensitive) for a list that is being continually updated with ACTIONABLE items for you to do to demonstrate your allyship and contribute to the change.
#blacklivesmatter ... See MoreSee Less
D4P is live!
The recency of COVID-19 has made it difficult to fully grasp how human immune systems respond to the SARS-CoV-2 infection. Yet, in order to create an accurate picture of COVID-19’s impact on society, this information is critical, particularly for serological (antibody) testing. It is clear that humans are producing antibodies against this virus. However, we still need to understand the specific types of antibodies being made, and how long after infection can we expect our bodies to make them. Our D4P Fellow, Dr. Odaelys Pollard, presents data from “Antibody responses to SARS-CoV-2 in patients with COVID-19,” which chronicles the antibody response from over 250 COVID-19 patients, and suggests a set of criteria for confirmation of infection. ... See MoreSee Less
Thank you all.
Great Job Sis
Hi cuz!!! Proud of you Dr. Odaelys Walwyn Pollard
How to keep IgMs from lowering during or after it is cleaned?
which antibody type is thought to provide long term immunity in humans to covid-19?
The correct answer is B - IgG!
Joe's talk can be found here: rockedu.rockefeller.edu/d4p/d4p-exploring-the-possibilities-of-reinfection/
As we near the end of this fantastic exploration into antibodies and covid-19, please start gathering your questions! Questions can be added, here, and will be shared with Dr. Pollard to be answered during our q&a!
Hello everyone and welcome to another week of data for the people! Where are you tuning in from today?
find fran's talk here: rockedu.rockefeller.edu/d4p/can-surgical-masks-prevent-viral-spread/
Check out Dr. Pollard's first talk here: rockedu.rockefeller.edu/d4p/testing-for-covid-19-immunity/
Which version of seroconversion is occurring with covid-19?
Ask us your questions! ⬇️⬇️⬇️
A) Synchronous seroconversion
What do you think?!
C) igG then igM
B) igM then igG
What do you think?
Please take our survey: www.surveymonkey.com/r/XDR6PB8 !
Please fill out our survey: www.surveymonkey.com/r/XDR6PB8
SO proud of the @RockefellerUniv students who organized their labs to get a #BlackLivesMatter sign above NYC’s FDR highway.
If you were one of the organizers, reply and introduce yourself (if you’d like) so I can RT. This is beautiful.
COVID-19 and Diabetes disproportionally affect minoritized populations. Join us now on #D4P as @WeillCornell graduate students @BelayViktor shares research on the intersection between COVID-19 and Diabetes.
Join our friends @rockedu_ as they continue to run this amazing project, helping us better understand health concerns surrounding COVID-19 https://t.co/ZxIrjEiRtx
As COVID-19 continues to influence + affect our lives, we strive to keep bringing you jargon-less science. Today on #D4P @BelayViktor will discuss the intersections between COVID-19 + Diabetes. Learn about how COVID-19 affects people in these populations.
After learning so much from the #inclusivescicomm community last fall, we at @rockedu_ noticed that some of our standard language was quite passive. We realized we needed to be more mindful to showcase that the inequities we see are a result of an ACTIVE system